Durham, NC - An initial dose of 162-mg aspirin may be as effective as and perhaps safer than 325 mg for the acute treatment of ST-elevation MI (STEMI), a new study suggests [1]. The study, published ...

In addition, the CURRENT-OASIS 7 study found no significant difference in major bleeding between the two doses (2.3% with 75–100 mg vs 2.3% with 300–325 mg; hazard ratio [HR]: 0.99; 95% CI: 0.84–1.17; ...

Please provide your email address to receive an email when new articles are posted on . Among patients with atherosclerotic CVD, there was no difference in CV events or major bleeding according to ...

Hyperglycaemia results diltiazem price cells are unable to take up and use glucose. When the renal This glycosuria causes osmotic diuresis and polyuria. Loss of fluid causes dehydration and increased ...

Please provide your email address to receive an email when new articles are posted on . We were unable to process your request. Please try again later. If you continue to have this issue please ...

(UPDATED) Treating patients with atherosclerotic cardiovascular disease (ASCVD) with low-dose aspirin is just as effective as using the 325-mg dose for the prevention of major cardiovascular events, ...

For the above reasons, Medindia cannot be held liable for any action taken based on the information provided by its website. The purpose of this website is to provide initial guidance only and it does ...

DEAR DR. ROACH: I am an 81-year-old female who has been on Xarelto for years due to my deep vein thrombosis (DVT). I also have an inferior vena cava (IVC) filter. I read that low-dose aspirin (325 mg) ...

CHAPEL HILL, N.C.--May 29, 2013-- POZEN Inc. (Nasdaq: POZN),a pharmaceutical company committed to transforming medicine that transforms lives, today announced that the U.S. Food and Drug ...

Presence of Gastric Erosions in Patients Taking Low-Dose Aspirin for Secondary Cardiovascular Prevention May Result in a 2-Fold Increase in Future Gastric Ulcers Results of a PA32540 Phase 3 Post-Hoc ...

CHAPEL HILL, N.C.--(BUSINESS WIRE)--POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to transforming medicine that transforms lives, today announced that it and Sanofi US have mutually ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. An error has occurred. Please try again ...